223 related articles for article (PubMed ID: 34482380)
1. Circular RNAs in osteoporosis: expression, functions and roles.
Luo Y; Qiu G; Liu Y; Li S; Xu Y; Zhang Y; Cao Y; Wang Y
Cell Death Discov; 2021 Sep; 7(1):231. PubMed ID: 34482380
[TBL] [Abstract][Full Text] [Related]
2. Roles of circular RNAs in osteogenic/osteoclastogenic differentiation.
Wang T; Zhang C; Xu L; Li X
Biofactors; 2024; 50(1):6-15. PubMed ID: 37534732
[TBL] [Abstract][Full Text] [Related]
3. Circular RNAs as potential regulators in bone remodeling: a narrative review.
Pan X; Cen X; Zhang B; Pei F; Huang W; Huang X; Zhao Z
Ann Transl Med; 2021 Oct; 9(19):1505. PubMed ID: 34805367
[TBL] [Abstract][Full Text] [Related]
4. Circular RNAs: Promising Targets in Osteoporosis.
Moura SR; Fernandes MJ; Santos SG; Almeida MI
Curr Osteoporos Rep; 2023 Jun; 21(3):289-302. PubMed ID: 37119447
[TBL] [Abstract][Full Text] [Related]
5. Role of LncRNAs and CircRNAs in Bone Metabolism and Osteoporosis.
Patil S; Dang K; Zhao X; Gao Y; Qian A
Front Genet; 2020; 11():584118. PubMed ID: 33281877
[TBL] [Abstract][Full Text] [Related]
6. Circular RNAs: typical biomarkers for bone-related diseases.
Hu L; Wu W; Zou J
J Zhejiang Univ Sci B; 2022 Dec; 23(12):975-988. PubMed ID: 36518051
[TBL] [Abstract][Full Text] [Related]
7. Long Non-coding RNAs: A New Regulatory Code for Osteoporosis.
Wu QY; Li X; Miao ZN; Ye JX; Wang B; Zhang F; Xu RS; Jiang DL; Zhao MD; Yuan FL
Front Endocrinol (Lausanne); 2018; 9():587. PubMed ID: 30349507
[TBL] [Abstract][Full Text] [Related]
8. CircHmbox1 Targeting miRNA-1247-5p Is Involved in the Regulation of Bone Metabolism by TNF-α in Postmenopausal Osteoporosis.
Liu Z; Li C; Huang P; Hu F; Jiang M; Xu X; Li B; Deng L; Ye T; Guo L
Front Cell Dev Biol; 2020; 8():594785. PubMed ID: 33425899
[TBL] [Abstract][Full Text] [Related]
9. New insights into the epigenetics of osteoporosis.
Letarouilly JG; Broux O; Clabaut A
Genomics; 2019 Jul; 111(4):793-798. PubMed ID: 29730394
[TBL] [Abstract][Full Text] [Related]
10. Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption.
Kitaura H; Marahleh A; Ohori F; Noguchi T; Shen WR; Qi J; Nara Y; Pramusita A; Kinjo R; Mizoguchi I
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708317
[TBL] [Abstract][Full Text] [Related]
11. Osteoblast-osteoclast interactions.
Chen X; Wang Z; Duan N; Zhu G; Schwarz EM; Xie C
Connect Tissue Res; 2018 Mar; 59(2):99-107. PubMed ID: 28324674
[TBL] [Abstract][Full Text] [Related]
12. The Role of Autophagy and Mitophagy in Bone Metabolic Disorders.
Wang S; Deng Z; Ma Y; Jin J; Qi F; Li S; Liu C; Lyu FJ; Zheng Q
Int J Biol Sci; 2020; 16(14):2675-2691. PubMed ID: 32792864
[TBL] [Abstract][Full Text] [Related]
13. Friend or Foe? Essential Roles of Osteoclast in Maintaining Skeletal Health.
Wang H; Yang G; Xiao Y; Luo G; Li G; Li Z
Biomed Res Int; 2020; 2020():4791786. PubMed ID: 32190665
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive circRNA expression profile and function network in osteoblast-like cells under simulated microgravity.
Cao Z; Zhang Y; Wei S; Zhang X; Guo Y; Han B
Gene; 2021 Jan; 764():145106. PubMed ID: 32889059
[TBL] [Abstract][Full Text] [Related]
15. DDR2 (discoidin domain receptor 2) suppresses osteoclastogenesis and is a potential therapeutic target in osteoporosis.
Zhang Y; Su J; Wu S; Teng Y; Yin Z; Guo Y; Li J; Li K; Yao L; Li X
Sci Signal; 2015 Mar; 8(369):ra31. PubMed ID: 25805889
[TBL] [Abstract][Full Text] [Related]
16. [Molecules which are involved in osteoclastic bone resorption: from the aspect of targets of treatment for osteoporosis].
Take I; Takahash N; Kurihara S
Clin Calcium; 2005 May; 15(5):741-6. PubMed ID: 15876734
[TBL] [Abstract][Full Text] [Related]
17. Osteoblasts and osteoclasts in bone remodeling and inflammation.
Tanaka Y; Nakayamada S; Okada Y
Curr Drug Targets Inflamm Allergy; 2005 Jun; 4(3):325-8. PubMed ID: 16101541
[TBL] [Abstract][Full Text] [Related]
18. The osteoclast, bone remodelling and treatment of metabolic bone disease.
Boyce BF; Rosenberg E; de Papp AE; Duong LT
Eur J Clin Invest; 2012 Dec; 42(12):1332-41. PubMed ID: 22998735
[TBL] [Abstract][Full Text] [Related]
19. Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.
Kalaitzoglou E; Popescu I; Bunn RC; Fowlkes JL; Thrailkill KM
Curr Osteoporos Rep; 2016 Dec; 14(6):310-319. PubMed ID: 27704393
[TBL] [Abstract][Full Text] [Related]
20. Regulatory mechanisms of osteoblast and osteoclast differentiation.
Katagiri T; Takahashi N
Oral Dis; 2002 May; 8(3):147-59. PubMed ID: 12108759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
